Compare FNB & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNB | CAI |
|---|---|---|
| Founded | 1864 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 4.7B |
| IPO Year | 2002 | N/A |
| Metric | FNB | CAI |
|---|---|---|
| Price | $17.74 | $16.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $19.70 | ★ $30.91 |
| AVG Volume (30 Days) | ★ 4.5M | 3.2M |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | ★ 22.83 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.12 | $25.24 |
| Revenue Next Year | $8.35 | $22.32 |
| P/E Ratio | $46.42 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.54 | $14.19 |
| 52 Week High | $19.14 | $42.50 |
| Indicator | FNB | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 46.97 |
| Support Level | $17.40 | $14.19 |
| Resistance Level | $17.86 | $19.79 |
| Average True Range (ATR) | 0.30 | 0.97 |
| MACD | 0.01 | 0.22 |
| Stochastic Oscillator | 89.38 | 48.74 |
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments, and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management, and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.